Serum Sulfhydryl Levels in Rheumatoid Patients Treated with Gold Thiomalate and Penicillamine
Matti Haataja, Martti Nissilä, Helka-Marjatta Ruutsalo
Abstract
Matti Haataja, Martti Nissilä, Helka-Marjatta Ruutsalo
Abstract
Twenty-six patients with rheumatoid arthritis were treated with sodium aurothiomalate (16 patients) and penicillamine (10 patients) for 9 months. During both treatment periods the content of serum sulfhydryl groups increased and erythrocyte sedimentation rate, rheumatoid factor titre and number of swollen joints decreased.
OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Twenty-six patients with rheumatoid arthritis were treated with sodium aurothiomalate (16 patients) and penicillamine (10 patients) for 9 months. During both treatment periods the content of serum sulfhydryl groups increased and erythrocyte sedimentation rate, rheumatoid factor titre and number of swollen joints decreased.
Key concepts: Penicillamine, Medicine, Rheumatoid arthritis, Gold Sodium Thiomalate, Erythrocyte sedimentation rate, Rheumatoid factor, Titer, Internal medicine